Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-05

Clinical Trial Update: Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether a paravertebral block can reduce the incidence of new onset atrial fibrillation after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: New Onset Atrial Fibrillation, Anesthesia, Local | Phase 4 | Status: COMPLETED